Scope:
Keywords:
Update

News about Eisai.Eu

76 days ago

Analyse the news about Eisai.Eu from multiple sources, get visualizations or extract the entire dataset.

Related dashboards:

Eisai eyes fiscal 2025 U.S. approval for home version of Alzheimer's drug

Read on: Nikkei link
76d ago

Patients on Alzheimer's drug Leqembi see benefits over three years, Eisai study says

Read on: CNBC News link
245d ago

European drug regulator rejects Alzheimer's treatment Leqembi from Biogen, Eisai

Read on: CNBC News link
253d ago

Japan's Eisai aims for 2030 U.S. release of new Alzheimer's drug

Read on: Nikkei link
282d ago

Eisai to offer Alzheimer's drug in China from July

Read on: Nikkei link
328d ago

Eisai seeks expanded use of Alzheimer's drug for prevention

Read on: Nikkei link
474d ago

After US approval, Japan OKs its first Alzheimer's drug. Leqembi was developed by Eisai and Biogen

Read on: ABC News link
561d ago

Dataset

Extract all news on this scope:

Analysis

See the trend on this scope:

Evolution through time

Sources analysis:

Distribution of sources in the news

Sections analysis:

Distribution of sections in the news

Current sentiment polarity: neutral with a score of 0.16

neutral 57%
positive 29%
negative 14%

Sentiment polarity through time